China
· Delayed Price · Currency is CNY Sino Biological,Inc. Statistics
Total Valuation
SHE:301047 has a market cap or net worth of CNY 7.72 billion. The enterprise value is 3.83 billion.
| Market Cap | 7.72B |
| Enterprise Value | 3.83B |
Important Dates
The next estimated earnings date is Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | May 20, 2025 |
Share Statistics
SHE:301047 has 121.64 million shares outstanding. The number of shares has decreased by -2.43% in one year.
| Current Share Class | 121.64M |
| Shares Outstanding | 121.64M |
| Shares Change (YoY) | -2.43% |
| Shares Change (QoQ) | -5.81% |
| Owned by Insiders (%) | 55.81% |
| Owned by Institutions (%) | 5.18% |
| Float | 40.03M |
Valuation Ratios
The trailing PE ratio is 79.41 and the forward PE ratio is 54.98.
| PE Ratio | 79.41 |
| Forward PE | 54.98 |
| PS Ratio | 12.53 |
| PB Ratio | 1.33 |
| P/TBV Ratio | 1.41 |
| P/FCF Ratio | 165.44 |
| P/OCF Ratio | 68.68 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.32, with an EV/FCF ratio of 81.96.
| EV / Earnings | 37.96 |
| EV / Sales | 6.21 |
| EV / EBITDA | 33.32 |
| EV / EBIT | 195.08 |
| EV / FCF | 81.96 |
Financial Position
The company has a current ratio of 22.47, with a Debt / Equity ratio of 0.01.
| Current Ratio | 22.47 |
| Quick Ratio | 21.95 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.52 |
| Debt / FCF | 1.28 |
| Interest Coverage | 5.17 |
Financial Efficiency
Return on equity (ROE) is 1.67% and return on invested capital (ROIC) is 0.20%.
| Return on Equity (ROE) | 1.67% |
| Return on Assets (ROA) | 0.20% |
| Return on Invested Capital (ROIC) | 0.20% |
| Return on Capital Employed (ROCE) | 0.33% |
| Revenue Per Employee | 603,941 |
| Profits Per Employee | 98,729 |
| Employee Count | 1,021 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 2.93 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.25% in the last 52 weeks. The beta is 1.00, so SHE:301047's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | -6.25% |
| 50-Day Moving Average | 62.18 |
| 200-Day Moving Average | 63.27 |
| Relative Strength Index (RSI) | 57.25 |
| Average Volume (20 Days) | 1,224,005 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301047 had revenue of CNY 616.62 million and earned 100.80 million in profits. Earnings per share was 0.80.
| Revenue | 616.62M |
| Gross Profit | 437.88M |
| Operating Income | 19.61M |
| Pretax Income | 110.99M |
| Net Income | 100.80M |
| EBITDA | 89.29M |
| EBIT | 19.61M |
| Earnings Per Share (EPS) | 0.80 |
Balance Sheet
The company has 3.96 billion in cash and 59.82 million in debt, giving a net cash position of 3.90 billion or 32.04 per share.
| Cash & Cash Equivalents | 3.96B |
| Total Debt | 59.82M |
| Net Cash | 3.90B |
| Net Cash Per Share | 32.04 |
| Equity (Book Value) | 5.79B |
| Book Value Per Share | 47.61 |
| Working Capital | 4.02B |
Cash Flow
In the last 12 months, operating cash flow was 112.45 million and capital expenditures -65.77 million, giving a free cash flow of 46.69 million.
| Operating Cash Flow | 112.45M |
| Capital Expenditures | -65.77M |
| Free Cash Flow | 46.69M |
| FCF Per Share | 0.38 |
Margins
Gross margin is 71.01%, with operating and profit margins of 3.18% and 16.35%.
| Gross Margin | 71.01% |
| Operating Margin | 3.18% |
| Pretax Margin | 18.00% |
| Profit Margin | 16.35% |
| EBITDA Margin | 14.48% |
| EBIT Margin | 3.18% |
| FCF Margin | 7.57% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 1.57%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 1.57% |
| Dividend Growth (YoY) | -50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 253.49% |
| Buyback Yield | 2.43% |
| Shareholder Yield | 4.01% |
| Earnings Yield | 1.31% |
| FCF Yield | 0.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 30, 2022. It was a forward split with a ratio of 1.9.
| Last Split Date | Mar 30, 2022 |
| Split Type | Forward |
| Split Ratio | 1.9 |
Scores
SHE:301047 has an Altman Z-Score of 19.81.
| Altman Z-Score | 19.81 |
| Piotroski F-Score | n/a |